EASD 2025 15 - 19 September 2025

Continuous glucose monitoring-based outcomes in adults with type 2 diabetes receiving IcoSema vs comparators: post hoc analysis of COMBINE 1 and 3

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.

Keywords

Diabetes

Congress short oral presentation

Insulin

IcoSema (Icodec Semaglutide)

PHASE 3 (RCT)